Sfoglia per AUTORE
MOSCA A
Collezione AO Cuneo

  

Items : 5

Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations. in Minerva urology and nephrology / Minerva Urol Nephrol. 2023 Aug;75(4):460-470. doi: 10.23736/S2724-6051.23.05369-7.

2023
AO Cuneo
ASL Cuneo 2
AOU Novara

Grande E; Santoni M; Buti S; Battelli N; Sorgentoni G; Pierantoni F; Monteiro FS; Rebuzzi SE; Roviello G; Soares A; Zabalza IO; Rizzo A; Bisonni R; Morelli F; Incorvaia L; Küronya Z; Mosca A; Bhuva D; Santini D; Vau N; Messina C; Merler S; Landmesser J; Grillone F; Ortega C; Sunela K; Ansari J; Atzori F; Bassanelli M; et alii...

Maintenance versus discontinuation of androgen deprivation therapy during continuous or intermittent docetaxel administration in castration-resistant prostate cancer patients: A multicentre, randomised Phase III study by the Piemonte Oncology Network. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Sep;155:127-135. doi: 10.1016/j.ejca.2021.06.034. Epub 2021 Aug 6.

2021
AO Cuneo
ASL Asti
ASL Biella
ASL Cuneo 2
AOU Città della Salute di Torino
ASL Città di Torino
AOU Novara

Tucci M; Baier S; Gennari A; Bellissimo AR; Ciccone G; Masini C; Sacco C; Amoroso D; Montagnani F; Comandone A; Ortega C; Buttigliero C; Fea E; Vanella P; Valcamonico F; Zamparini M; Sirotova Z; Chiappino I; Bianchi S; Mosca A; Dalla Volta A; Prati V; Dal Canton O; Berruti A;

First-line pazopanib in patients with advanced non-clear cell renal carcinoma: An Italian case series. in World journal of clinical oncology / World J Clin Oncol. 2021 Nov 24;12(11):1037-1046. doi: 10.5306/wjco.v12.i11.1037.

2021
AO Cuneo

Petrelli F; Naglieri E; Fea E; Berruti A; Fornarini G; Facchini G; Procopio G; Boccardo F; Galli L; Caserta C; Carteni G; Basso U; Aurilio G; Caffo O; De Giorgi U; Massari F; Bersanelli M; Buti S; Iacovelli R; Porta C; Mosca A;

Maintenance versus discontinuation of androgen deprivation therapy during docetaxel administration with a continuous or an intermittent schedule in metastatic, castration resistant, prostate cancer patients: A multicenter randomized phase III study of the Piemonte Oncology Network in Annals of Oncology

2020
ASL Biella
ASL Città di Torino
ASL Asti
AO Cuneo
ASL Cuneo 2
AOU Città della Salute di Torino

Fea E; Buttigliero C; Montagnani F; Comandone A; Gennari A; Tucci M; Chiappino I; Canton OD; Masini C; Sacco† C; Amoroso D; Sirotova Z; Ciccone G; Valcamonico F; Vanella P; Ortega C; Prati V; Bianchi S; Mosca A; Berruti A;

Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors. in Cancers / Cancers (Basel). 2019 Dec 30;12(1):84. doi: 10.3390/cancers12010084.

2019
ASL Cuneo 2
AO Cuneo

Piva F; Cimadamore A; Montironi R; Battelli N; Rizzo M; Merler S; Sorgentoni G; Conti A; Verzoni E; Scagliarini S; Sepe P; Cheng L; Paolucci V; Graham J; Pierce E; Lopez-Beltran A; Atzori F; Scarpelli M; Ortega C; Incorvaia L; Vau N; Iacovelli R; Mosca A; Gelibter A; Carrozza F; Martignetti A; Morelli F; Caffo O; Zucali P; et alii...